Multiple Myeloma – Multiple Myeloma New Zealand

New Zealand sits at the bottom of the western world for access to modern medicines. Pharmac decide what drugs we...

American multiple myeloma patient Andrew Sninsky, 75, is cycling around New Zealand to raise awareness of a cancer without a...

It takes the nation’s drug-buying agency, Pharmac, an average of 7.7 years to make funding decisions about potentially life-saving medicines, a...

In the first two months of 2021, 27 patients were harmed by cancer treatment delays, the Otago Daily Times reported. Three became so...

Myeloma New Zealand has made a submission on the Therapeutic Products Bill, as it has implications for Myeloma Patients. The...

Nathaniel works in the research team, where the CAR T-cells are designed, and supports both the GMP team, where the...

Download the ClinTrial Refer App